Events

Evidence Requirements for Reimbursement and HTA of Medical Devices in Europe

Regulatory approval does not automatically provide the clinical and health economic evidence needed to secure reimbursement, obtain a positive HTA recommendation, or support routine adoption of a medical device across Europe. This online seminar will explain how evidence expectations vary by country and pathway. It will review typical expectations about comparator, patient population, study designs, duration of follow-up and outcomes. It will also examine when health economic evidence may be required, and how manufacturers can identify evidence gaps and align development programs with future reimbursement and HTA needs. The seminar will be delivered by Dr Oleg Borisenko on 29 October 2026 at 17:00 CET, is open only to representatives of the medical technology industry, and will not be recorded.

ISPOR Europe 2026: Booth #416

MTRC is joining ISPOR Europe 2026 in Vienna on 8–11 November — a great venue to discuss the evolving evidence requirements and reimbursement challenges shaping market access for medical technologies in Europe. Visit us at booth #416 to meet our team, or book a meeting in advance with MTRC Director Oleg Borisenko to discuss your specific European market access and evidence strategy needs.

MedTech Market Access in 2026: Key Developments and What Comes Next

The European MedTech market access environment continued to evolve in 2026, with important developments in reimbursement, healthcare policy, HTA methodology, national access pathways, and innovative payment mechanisms. This online seminar will review the most significant developments of the year, including progress in implementing EU Joint Clinical Assessments for selected medical devices and IVDs. It will explain how these changes may affect evidence generation, reimbursement strategy, country prioritization, launch sequencing, and time to access, while highlighting practical actions manufacturers should consider for 2027 and beyond. The seminar will be delivered by Dr Oleg Borisenko on 17 December 2026 at 17:00 CET, is open only to representatives of the medical technology industry, and will not be recorded.